Humacyte (HUMA) Change in Receivables (2020 - 2026)
Humacyte (HUMA) reported Change in Receivables of -$7000.0 for Q1 2026, down 102.27% year-over-year from $308000.0 in Q1 2025, and up 98.9% quarter-over-quarter from -$637000.0 in Q4 2025.
Humacyte (HUMA) Change in Receivables (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 6 years of Change in Receivables data on file, last reported at -$7000.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at -$7000.0, down 102.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$54000.0 (down 117.53% YoY), and the FY2025 annual result was $261000.0, changed N/A from the prior year.
- Change in Receivables climbed to -$7000.0 in Q1 2026 per HUMA's latest filing, from -$637000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.1 million in Q2 2022 and troughed at -$1.3 million in Q3 2022.
- A 4-year average of $8666.7 and a median of -$7000.0 in 2026 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 100.0% in 2022 and fell as far as 182.85% in 2022.
- A 4-year view of Change in Receivables shows it stood at -$1.3 million in 2022, then jumped by 97.56% to -$31000.0 in 2023, then tumbled by 1954.84% to -$637000.0 in 2025, then jumped by 98.9% to -$7000.0 in 2026.
- Business Quant data shows HUMA's Change in Receivables at -$7000.0 in Q1 2026, -$637000.0 in Q4 2025, and $684000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -4.08 Mn |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | -7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | -637,000.00 |
| Dec 31, 2025 | -637,000.00 |
| Sep 30, 2025 | 684,000.00 |
| Sep 30, 2025 | 684,000.00 |
| Jun 30, 2025 | -94,000.00 |
| Jun 30, 2025 | -94,000.00 |
| Mar 31, 2025 | 308,000.00 |
| Mar 31, 2025 | 308,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Sep 30, 2022 | -1.27 Mn |
| Sep 30, 2022 | -1.27 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 57,000.00 |
| Mar 31, 2022 | 57,000.00 |
| Dec 31, 2021 | -64,000.00 |
| Dec 31, 2021 | -64,000.00 |